ResMed Completes Acquisition of Noctrix Health for $340 Million
June 1, 2026
ResMed completed its acquisition of Noctrix Health, a medical device company developing wearable therapeutics for chronic neurological disorders. The deal expands ResMed’s clinical sleep health portfolio with Noctrix’s Nidra Tonic Motor Activation (TOMAC) therapy for moderate-to-severe Restless Legs Syndrome (RLS), with Noctrix becoming a wholly owned subsidiary. The acquisition was previously announced as a definitive merger agreement to acquire Noctrix for $340 million, expected to close on or around June 1, 2026.
- Buyers
- ResMed
- Targets
- Noctrix Health, Inc.
- Sellers
- Treo Ventures
- Industry
- Medical Devices
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Nexus Acquires Telemetrix RPM
July 31, 2026
Healthcare Services
Nexus (formerly Nexus Bedside) acquired Telemetrix RPM, a remote patient monitoring and chronic care management company. The deal closed on July 23, 2026, and Telemetrix RPM now operates as a wholly owned subsidiary of Nexus. Financial terms were not disclosed.
-
Resonetics Completes Acquisition of Resolution Medical
January 27, 2026
Healthcare Services
Resonetics completed its acquisition of Resolution Medical, expanding its end-to-end design, finished-device, and sub-assembly capabilities for interventional, structural heart, and neuromodulation markets. The deal integrates Resolution Medical’s biosimulation, NPI, and cleanroom assembly expertise with Resonetics’ AGILE Product Development group and advanced manufacturing capabilities.
-
ResMed Acquires Somnoware
July 5, 2023
Healthcare Services
ResMed has acquired privately held Somnoware, a U.S.-based provider of cloud-based sleep and respiratory care diagnostics software, to expand its upstream sleep management capabilities and better connect diagnosis workflows with ResMed's treatment ecosystem. ResMed plans to retain Somnoware staff, integrate the platform into its solution portfolio while keeping it open and device-agnostic, and did not disclose material financial terms.
-
Nox Health Acquires Somryst from Pear Therapeutics
May 25, 2023
Healthcare Services
Nox Health, a global sleep health company based in Alpharetta, Georgia, has acquired Somryst—the FDA-cleared prescription digital therapeutic for chronic insomnia—purchased from Pear Therapeutics. The acquisition brings an outcomes-validated insomnia treatment into Nox's value-based sleep care programs to expand its clinical offerings for employers, health plans and health systems.
-
Vestar Capital Partners Invests Growth Capital in Nox Health
November 30, 2022
Healthcare Services
Vestar Capital Partners has made a strategic growth investment in Nox Health to accelerate development of the company's sleep diagnostic technology and expand adoption of its value-based sleep management solutions among employers and health plans. Financial terms were not disclosed; the investment will support product and service development and broader market expansion.
-
ZOLL Medical Corporation Acquires Respicardia, Inc.
April 12, 2021
Medical Devices
ZOLL Medical Corporation, an Asahi Kasei company, acquired Respicardia, Inc., the developer of the implantable remēde® System for treating moderate to severe Central Sleep Apnea (CSA). The acquisition brings Respicardia’s FDA-approved neurostimulation technology and employees into ZOLL’s cardiac and respiratory care portfolio to expand treatment capabilities and global reach.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.